DUBLIN–(BUSINESS WIRE)– <\/p>\n
Dublin – Research and Markets (http:\/\/www.researchandmarkets.com\/research\/2z54ns\/therapy_trends_mu<\/a>) has announced the addition of the “Therapy Trends: Multiple Sclerosis” report to their offering. <\/p>\n On the cusp of a treatment revolution <\/p>\n An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse future trends. <\/p>\n Multiple Sclerosis: On the cusp of a treatment revolution <\/p>\n The year 2012 will see landmark changes in the treatment of MS. Gilenya, the first novel drug in five years, is to be joined by three new products; BG-12 from Biogen Idec, Sanofi’s Aubagio and Genzyme’s Lemtrada. These drugs will partially satisfy substantial unmet needs of convenient administration and more efficacious therapy to drive unprecedented market growth. <\/p>\n Driven by in-depth interviews with the world’s leading multiple sclerosis KOLs, Therapy Trends: Multiple Sclerosis uncovers how the current treatment landscape will be impacted by significant future events, with particular focus on pipeline therapies and how these will modify the way MS is managed by neurologists in the future. <\/p>\n Drive your strategic decision-making with inside intelligence <\/p>\n Therapy Trends: Multiple Sclerosis disseminates critical opinion and analysis to provide premier research. <\/p>\n – We cut to the heart of market-changing events and eliminate superfluous background information so you can focus on developments of greatest strategic impact and reduce your reaction time <\/p>\n<\/p>\n Read the original post: Source: DUBLIN–(BUSINESS WIRE)– Dublin – Research and Markets (http:\/\/www.researchandmarkets.com\/research\/2z54ns\/therapy_trends_mu<\/a>) has announced the addition of the “Therapy Trends: Multiple Sclerosis” report to their offering. On the cusp of a treatment revolution An incisive report and dynamic analyst briefing service delivering insight from … Continue reading
\nResearch and Markets: Therapy Trends: Multiple Sclerosis<\/a><\/p>\n
http:\/\/www.longevitymedicine.tv\/feed\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"